ArticleCardiovascular therapeutics2023

Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway.

Anwu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.